Condition

PIK3CA Gene Mutation

ClinicalTrials.gov condition label

Clinical trials1

Recruiting0

Common interventions3

Lead sponsors shown1

Clinical trials

1 shown

A Phase 1/2a Study of K-1728 in Advanced Solid TumorsNCT07861932 · 2026-10-01

NOT_YET_RECRUITING

Common interventions

FulvestrantDRUG1K-1728DRUG1PalbociclibDRUG1

Leading sponsors

KymaThera, Inc.1

Trial status mix

NOT_YET_RECRUITING1

Phase mix

PHASE11

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.